The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation Marion A. Hofmann BowmanAnn Marie Schmidt Clinical Implications 07 November 2013 Pages: 1329 - 1331
Aptamers: multifunctional molecules for biomedical research Jayeeta BanerjeeMarit Nilsen-Hamilton Review 18 September 2013 Pages: 1333 - 1342
FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD Denise OrozcoDieter Edbauer Review 24 August 2013 Pages: 1343 - 1354
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications—a review Antonio MacciòClelia Madeddu Review 21 September 2013 Pages: 1355 - 1368
The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth Hyun-Jin TaeJi Min KimLi Lin Original Article 17 October 2013 Pages: 1369 - 1381
PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment Linhua JinYoko TabeMarina Konopleva Original Article 18 August 2013 Pages: 1383 - 1397
The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism Jose Felix Martí-MassóAlberto BergarecheCoro Paisán-Ruiz Original Article 20 August 2013 Pages: 1399 - 1406
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization Massimo Dal MonteGiovanni CasiniPaola Bagnoli Original Article 02 August 2013 Pages: 1407 - 1419
R-spondin 1 promotes vibration-induced bone formation in mouse models of osteoporosis Haitao WangTracy A. BrennanRobert J. Pignolo Original Article 24 August 2013 Pages: 1421 - 1429